Skip to content

Sutures for skin closure in caesarean section

Subcuticular skin closure in Caesarean section polyglactin-910 (Vicaryl Rapid) versus poliglecaprone-25 (Monocryl) – A randomised control trial - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077587
Enrollment
400
Registered
2024-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O754- Other complications of obstetric surgery and procedures

Interventions

Intervention1: Subcuticular skin closure with Polyglactin 910 (Vicryl Rapide) suture number 2-0 IN women UNDERGOING LSCS: All women satisfying the inclusion and exclusion criteria and requiring LSCS

Sponsors

Associate Professor AIIMS Bilaspur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women aged 18-40 years 2. undergoing LSCS for various indications in the labour ward of Obstetrics & gynaecology, AIIMS, Bilaspur (H.P.) & IGMC Shimla during the study period

Exclusion criteria

Exclusion criteria: 1. Obesity - booking BMI >30 2. Vertical skin incision 3. Previous vertical abdominal scar 4. Any signs/symptoms suggestive of infection like chorioamnionitis, fever or UTI in the last 2 weeks, 5. Women on systemic steroids/ immune compromised 6. Local skin lesions/ infections 7. Haemodynamically unstable patient 8. Women with GDM/pre-gestation DM on insulin 9. Chronic renal disease, inflammatory bowel disease 10. Preterm LSCS ( 11. Anaemia with Hb 12. Multiple pregnancy.

Design outcomes

Primary

MeasureTime frame
composite wound complications defined as per CDC guidelines as: surgical site infection (culture-positive SSI), wound haematoma or seroma (defined as at least moderate serous fluid collection or subcutaneous blood collection) or wound dehiscence (wound separation of 1 cm or more in length) within 30 days following LSCSTimepoint: within 30 days following LSCS

Secondary

MeasureTime frame
1. Post-operative pain: assessed by Visual Analogue Scale (VAS) (12)on day 1 and day 2 post-operative. (Timepoint: day 1 and day 2 post-op;2. Cosmetic Outcome: assessed by patient satisfaction and observer assessment at 6 weeks post-operative, and the presence of a hypertrophic and hyperpigmented scar anytime till 6 weeks post-operative. (will be assessed by Patient Scar Assessment Scale (PSOAS) and Observer Scar Assessment ScaleTimepoint: 6 weeks post-op

Countries

India

Contacts

Public ContactDr Harpreet Kaur

Associate Professor, All India Institute of Medical Sciences, Bilaspur, Himachal Pradesh, India

drharpreetsidhu7@gmail.com9872221818

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026